Computed Tomographic Findings of Postoperative Seroma in Breast Cancer Patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Seroma formation at the surgical site is a common finding in postoperative breasts and should not be mistaken for tumor recurrence on imaging studies. The purpose of this study was to describe the computed tomography (CT) findings of postoperative seromas in patients who underwent surgery for breast cancer. Methods: The CT findings of surgical site seromas were evaluated retrospectively in 171 breast cancer patients who underwent surgery from January to December 2010. Chest CT is recommended twice a year for the first 3 years postoperatively and annually thereafter; we evaluated the incidence of surgical site seroma and the imaging findings on CT images. Results: Seroma (mean maximal diameter, 21 mm) was observed in 34 patients (29 at the mastectomy site and 6 at the axillae) on the initial follow-up CT. The lesion shapes included round (n=11), oval (n=12), and triangular (n=12). Most of the seromas (n=33) showed homogeneous attenuation, and all exhibited mild peripheral rim enhancement. During a median follow-up of 38 months (range, 10–50 months), 60% of seromas diminished in size and resolved completely at a mean 24 months postoperatively. The remainder of seromas (n=14) persisted, though were smaller. Conclusion: Approximately 20% of surgically treated breast cancer patients had surgical site seromas visible on CT 6 months after surgery. The seromas varied in appearance, but should not be mistaken for tumor recurrence.
Abstract
Purpose: Seroma formation at the surgical site is a common finding in postoperative breasts and should not be mistaken for tumor recurrence on imaging studies. The purpose of this study was to describe the computed tomography (CT) findings of postoperative seromas in patients who underwent surgery for breast cancer. Methods: The CT findings of surgical site seromas were evaluated retrospectively in 171 breast cancer patients who underwent surgery from January to December 2010. Chest CT is recommended twice a year for the first 3 years postoperatively and annually thereafter; we evaluated the incidence of surgical site seroma and the imaging findings on CT images. Results: Seroma (mean maximal diameter, 21 mm) was observed in 34 patients (29 at the mastectomy site and 6 at the axillae) on the initial follow-up CT. The lesion shapes included round (n=11), oval (n=12), and triangular (n=12). Most of the seromas (n=33) showed homogeneous attenuation, and all exhibited mild peripheral rim enhancement. During a median follow-up of 38 months (range, 10–50 months), 60% of seromas diminished in size and resolved completely at a mean 24 months postoperatively. The remainder of seromas (n=14) persisted, though were smaller. Conclusion: Approximately 20% of surgically treated breast cancer patients had surgical site seromas visible on CT 6 months after surgery. The seromas varied in appearance, but should not be mistaken for tumor recurrence.
참고문헌 (11)
- Siegel R, "Cancer statistics, 2013", CA Cancer J Clin, 63, pp.11~30 (2013)
- Chansakul T, "The postconservation breast: part 1, expected imaging findings", AJR Am J Roentgenol, 198, pp.321~330 (2012)
- "Clinical practice guidelines in oncology - v.3" (2013)[URL]
- Khatcheressian JL, "Breast cancer follow-up and management after primary treatment : American Society of Clinical Oncology clinical practice guideline update", J Clin Oncol, 31, pp.961~965 (2013)
- Kumar S, "Post-mastectomy seroma : a new look into the aetiology of an old problem", J R Coll Surg Edinb, 40, pp.292~294 (1995)
- Vivek Srivastava, "Seroma Formation after Breast Cancer Surgery: What We Have Learned in the Last Two Decades", Journal of Breast Cancer, 15(4), pp.373~380 (2012), 한국유방암학회[DOI]
- Gonzalez EA, "Seroma formation following breast cancer surgery", Breast J, 9, pp.385~388 (2003)
- Purushotham AD, "Morbidity after sentinel lymph node biopsy in primary breast cancer : results from a randomized controlled trial", J Clin Oncol, 23, pp.4312~4321 (2005)
- Grunfeld E, "Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update)", CMAJ, 172, pp.1319~1320 (2005)
- Khatcheressian JL, "American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting", J Clin Oncol, 24, pp.5091~5097 (2006)
- Emens LA, "The follow-up of breast cancer", Semin Oncol, 30, pp.338~348 (2003)